Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Allergy Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Allergy Other
    Ultra-Short Course of Subcutaneous Immunotherapy Well Tolerated in Patients With Seasonal Allergic Rhinoconjunctivitis: Presented at EAACI - (DGDispatch)
    Sublingual Immunotherapy Even More Effective During Pollen Peak Season in Children With Rhinoconjunctivitis: Presented at EAACI - (DGDispatch)
    Children and Adolescents With Grass-Pollen-Allergic Rhinoconjunctivitis Benefit Similarly From 5-Grass Sublingual Monotherapy: Presented at EAACI - (DGDispatch)
    Sublingual Monotherapy Improves Quality of Life in Polysensitised Patients With Allergic Rhinitis: Presented at EAACI - (DGDispatch)
    Recombinant Bet v 1 Sublingual Tablets in Birch Allergy Well Tolerated Up to 50 mcg: Presented at EAACI - (DGDispatch)

    News archive

     Recent webcasts/CME - Allergy Other
    • Alpha1-Antitrypsin Deficiency: Incidence, Screening, and Management
    • Early Detection of Alpha1-Antitrypsin (AAT) Deficiency Helps Prevent Disease Progression
    • What Is the Best Approach to Treating Alpha1-Antitrypsin (AAT) Deficiency?
    • Improving Outcomes for Patients With Allergic Rhinitis: An Update From Philadelphia
    • Recognition and Management of Anaphylaxis

      Webcasts/CME archive

       Recent cases - Allergy Other
        Acute Allergic Reaction due to Milk Proteins Contaminating Lactose Added to Corticosteroid for Injection
        Acute Generalized Exanthematous Pustulosis (AGEP) Triggered by a Spider Bite
        Anaphylactic Reaction to Camomile Tea
        Acute Allergic Interstitial Nephritis After Use of Pantoprazole
        Allergic Enterocolitis and Protein-Losing Enteropathy as the Presentations of Manganese Leak From an Ingested Disk Battery: A Case Report

        Cases archive
          




        my personal edition > allergy other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Fluticasone Outperforms Levocabastine In Drug-Induced Rhinitis: Presented at EAACI

        By Michael Smith

        AMSTERDAM, THE NETHERLANDS -- June 15, 2004 -- Fluticasone is more effective than is levocabastine in treating rhinitis caused by over-use of nasal decongestants, say Polish researchers.

        Presenting findings at the 23rd Congress of the European Academy of Allergology and Clinical Immunotherapy (EAACI), Andrzej Wojdas, MD, of Warsaw's Military Medical Institute, said, "Drug-induced rhinitis … is the negative influence of pharmacological substances applied to the nasal mucosa." The most common culprits are the alphamimetic nasal decongestants.

        The approved treatment for this form of rhinitis is cessation of nose drops and administration of corticosteroids and antihistamines. To evaluate and compare the effectiveness of 2 nasally administered drugs, fluticasone (a corticosteroid) and levocabastine (a selective antihistamine whose primary indication is for ophthalmic use), Dr. Wojdas and colleagues studied 62 patients (33 males) aged 25 to 58 who had been diagnosed with drug-induced rhinitis, based on history, a physical exam, dermal tests and specific immunoglobulin E levels.

        The patients were assigned to 1 of 4 groups: group 1 received fluticasone, group 2 received levocabastine, group 3 received both drugs, and the control group received an inert physiological solution. Fluticasone was administered once a day, 100 micrograms into each nostril. Levocabastine was administered twice per day into each nostril. For those in the control group, the solution were administered by aerosol into each nasal tract. Treatment was for 6 weeks.

        The investigators considered the intensity of nasal discharge, the patients' feeling of nasal obstruction, and the patients' life quality and general well-being – all evaluated on a 10-point scale. They also looked at the appearance of the nasal mucosa, and the continuing need for nasal decongestants.

        Both of the fluticasone groups did significantly better than did either the control group or the group using levocabastine alone, Dr. Wojdas said.

        However, when the 2 groups getting fluticasone -- fluticasone alone and fluticasone plus levocabastine – were compared, the researchers obtained similar results, implying that the levocabastine was playing a lesser role in the therapeutic effect.

        Based on these findings, the researchers concluded that fluticasone is more effective than is levocabastine in treating drug-induced rhinitis.


        251 - Fluticasone vs. levocabastine in the treatment of drug-induced rhinitis



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send